Cancer-related pathways reveal potential treatment target for congenital heart disease
Tuesday, February 22, 2011 - 07:30
in Health & Medicine
(PhysOrg.com) -- Cross-disciplinary teams of scientists studying genetic pathways that are mutated in many forms of cancer, but which also cause certain forms of congenital heart disease, including hypertrophic cardiomyopathy (HCM), have introduced these mutations into mice and successfully treated HCM in the lab.